Cargando…
Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus
BACKGROUND: Anti-Embolism (AE) devices therapy is an additional antithrombotic treatment that is effective in many venous diseases, but the correlations between this medical compression therapy and cardiovascular arterial disease or comorbid diabetes mellitus (DM) are still controversial. In this st...
Autores principales: | Huang, Xiaxuan, Zhang, Luming, Xu, Mengyuan, Yuan, Shiqi, Ye, Yan, Huang, Tao, Yin, Haiyan, Lyu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343674/ https://www.ncbi.nlm.nih.gov/pubmed/35928930 http://dx.doi.org/10.3389/fcvm.2022.948924 |
Ejemplares similares
-
Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus
por: Huang, Xiaxuan, et al.
Publicado: (2023) -
Association between statin use and the prognosis of patients with acute myocardial infarction complicated with diabetes
por: Lu, Xuehao, et al.
Publicado: (2022) -
Antithrombotic Therapy Improves ICU Mortality of Septic Patients with Peripheral Vascular Disease
por: Yuan, Shiqi, et al.
Publicado: (2022) -
Associations of HDL-C/LDL-C with myocardial infarction, all-cause mortality, haemorrhagic stroke and ischaemic stroke: a longitudinal study based on 384 093 participants from the UK Biobank
por: Yuan, Shiqi, et al.
Publicado: (2022) -
Diagnostic and Prognostic Biomarkers for Myocardial Infarction
por: Wu, Yuling, et al.
Publicado: (2021)